Request Deal Involvement
Frazier Life Sciences led a $182m Series C round in Bluejay Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Argot Partners
or
Principals
bidder
ARKIN BIO VENTURES
bidder
HBM HEALTHCARE INVESTMENTS
bidder
FRAZIER HEALTHCARE PARTNERS
bidder
OCTAGON CAPITAL
target
BLUEJAY THERAPEUTICS
bidder
RA CAPITAL MANAGEMENT
bidder
T. ROWE PRICE GROUP INC
bidder
RIVERVEST VENTURE PARTNERS
bidder
UNICORN CAPITAL PARTNERS
bidder
WELLINGTON MANAGEMENT
bidder
NOVO HOLDINGS A/S
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite